chartexchange

PRQR
ProQR Therapeutics N.V.
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
1.08USD-6.087%(-0.07)881,588
Pre-marketNov 18, 2026 9:27:30 AM EST
1.15USD0.000%(0.00)
After-hoursNov 18, 2026 4:00:30 PM EST
1.10USD+1.852%(+0.02)
Loading…
Loading…
154.05M
Healthcare
Biotechnology
CEO
Daniel De Boer
HQ
Leiden, Zuid Holland, Netherlands
Previous Close
$1.15
Beta
1.88
52-Week High
$2.49 2025-12-16
52-Week Low
$1.07 2026-11-18
SMA 50
$1.52
SMA 200
$1.67
Avg. Vol 10D
630,189
Avg. Vol 30D
864,937
Avg. Vol 90D
815,539
Relative Vol
1.02
141.33M
91.44M
0.4100%
1,800,000
489
PRQR Profile

proqr therapeutics is a leiden, nl based biotech company focused on developments of drugs to treat genetic disorders. based on a novel proprietary technology we discover and develop drugs to change the lives of patients around the world. founded by industry icons and based on ground breaking science we strive to make a meaningful impact. check out our website for vacancies: www.proqr.com

PRQR Performance
PeriodPriceDateChangeBeta
1W1.362026-11-12-19.85%9.659
1M1.312026-10-19-16.79%1.962
3M2.222026-08-19-50.90%1.786
6M1.432026-05-19-23.78%1.833
1Y2.032025-11-19-46.30%1.883
2Y3.602024-11-19-69.72%—
5Y7.772021-11-19-85.97%1.120
PRQR Stock Summary

ProQR Therapeutics N.V. (NASDAQ:PRQR) stock price today is $1.09, and today's volume is 881,588. PRQR is down 5.217% today. The 30 day average volume is 864,937. PRQR market cap is $154.05M with 141.33M shares outstanding.